Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation (Prevention of Stroke)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02262676
What this trial is testing

Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

Who this might be right for
Atrial Fibrillation
Bayer 2,251
Not applicableUnknownNCT04637230
What this trial is testing

Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms

Who this might be right for
Sinus RhythmAtrial FibrillationAtrial Premature Complexes+2 more
A-Rhythmik GmbH 10,000
Post-approval studies (Phase 4)Study completedNCT01493557
What this trial is testing

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,067
Not applicableUnknownNCT03108872
What this trial is testing

Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sejong General Hospital 300
Not applicableStudy completedNCT01805531
What this trial is testing

Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication

Who this might be right for
Atrial Fibrillation
Bayer 411
Not applicableUnknownNCT01593553
What this trial is testing

Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden

Who this might be right for
Atrial FibrillationStroke
Karolinska University Hospital 7,173
Not applicableStudy completedNCT03563937
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon

Who this might be right for
Atrial Fibrillation
Bayer 64,920
Not applicableStudy completedNCT02470767
What this trial is testing

An Observational Cross-sectional Study Evaluating the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism, Who Are on Treatment to Adequately Control Their Coagulation and Treated in Primary Care Centres

Who this might be right for
StrokePrevention and ControlAtrial Fibrillation
Bayer 792
Not applicableLooking for participantsNCT05900414
What this trial is testing

RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University of Calgary 60
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Not applicableStudy completedNCT01947959
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 665,533
Large-scale testing (Phase 3)Study completedNCT02283294
What this trial is testing

Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

Who this might be right for
Transient Ischemic AttackStrokeAtrial Fibrillation
University of South Florida 91
Not applicableStudy completedNCT02640222
What this trial is testing

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 321,501
Not applicableStudy completedNCT01942031
What this trial is testing

Improved Prevention of Stroke in Primary Care in Stockholm, Sweden (Förbättrad Prevention av Stroke)

Who this might be right for
Ischemic StrokeHemorrhagic StrokeTIA+1 more
Karolinska Institutet 204
Not applicableNot Yet RecruitingNCT06564012
What this trial is testing

Wearable Cardiac Monitor to Enhance Detection of Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation

Who this might be right for
Atrial FibrillationArrhythmias, CardiacHeart Diseases+2 more
Sunnybrook Health Sciences Centre 100
Not applicableStudy completedNCT04722679
What this trial is testing

Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.

Who this might be right for
Non-Valvular Atrial Fibrillation
Bayer 103
Not applicableActive Not RecruitingNCT06580275
What this trial is testing

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

Who this might be right for
Atrial FibrillationStroke Prevention
Conformal Medical, Inc 80
Not applicableUnknownNCT04282993
What this trial is testing

Wearable Devices for Secondary Prevention of Ischemic Stroke

Who this might be right for
Stroke, IschemicAtrial Fibrillation
Campus Bio-Medico University 200
Not applicableStudy completedNCT03284762
What this trial is testing

Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment-naïve Asian Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Bayer 1,216
Not applicableWithdrawnNCT03804125
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Who this might be right for
Cerebral StrokeThrombosis, Deep VeinPulmonary Embolism
Pfizer
Next Page